Corpus ID: 3661837

Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.

@article{Chatterjee2013RandomisedPD,
  title={Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.},
  author={Suparna Chatterjee and P. Kar and T. Das and Sayantan Ray and Satyabrata Gangulyt and C. Rajendiran and M. Mitra},
  journal={The Journal of the Association of Physicians of India},
  year={2013},
  volume={61 10},
  pages={
          708-12
        }
}
  • Suparna Chatterjee, P. Kar, +4 authors M. Mitra
  • Published 2013
  • Medicine
  • The Journal of the Association of Physicians of India
  • AIMS To evaluate the effectiveness, safety and tolerability of a probiotic formulation containing Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 in the prevention of antibiotic associated diarrhoea (AAD. [...] Key Method The effectiveness of a 14-day therapy (concomitant with antibiotic course and seven days thereafter) of the probiotic formulation in preventing AAD was evaluated.Expand Abstract
    An introduction of the role of probiotics in human infections and autoimmune diseases
    • 6

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 14 REFERENCES
    Probiotics for the Prevention of Antibiotic-associated Diarrhea and Clostridium difficile Diarrhea
    • 105